A study on pancreatic cancer patients who underwent potentially curative pancreatic resection also showed that cytoplasmic HuR staining is a positive predictor of gemcitabine sensitivity and good prognosis (185). This evidence concerns the gene ELAVL1 and familial pancreatic carcinoma.